Ticker
LPCNCompany Name
LIPOCINE INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | EBITDA Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -4.45M | -105.78% | $ 4.21M |
3/31/2025 | $ -5.32M | -144.8% | $ 3.67M |
12/31/2024 | $ 50.14K | 0.45% | $ 11.2M |
9/30/2024 | $ -4.02M | -50.76% | $ 7.92M |
6/30/2024 | $ -8.45M | -176.1% | $ 4.8M |
3/31/2024 | $ -8.94M | -189.65% | $ 4.71M |
12/31/2023 | $ -16.32M | 0% | $ -2.85M |
9/30/2023 | $ -16.28M | 0% | $ -3.07M |
6/30/2023 | $ -12.04M | -21893.42% | $ 54.99K |
3/31/2023 | $ -11.12M | -2003.69% | $ 554.99K |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBITDA / Revenues
(=) EBITDA %
EBITDA % for LIPOCINE INC is calculated as follows: EBITDA [ $ -20.05M ] / Revenues [ $ 0 ]
(=) EBITDA % [ 0% ]
Minimum
Sep 30, 2021
Maximum
Sep 30, 2022
Average
Median
filtered constituents | 3.29K |
---|---|
min | -74.33% |
max | 97.24% |
average | 16.2% |
median | 14.74% |
std | 26.73% |